Sputnik Awaits India Nod After 91% Efficacy Results

The Sputnik vaccine made by Russia's Gamaleya Institute has showed close to 91% efficacy against SARS-CoV-2 as the makers published in the Lancet. Dr. Reddy's which is going to be manufacturing the vaccine in India now awaits a nod from the Drugs Controller General of India to initiate the distribution of the vaccine.